Proteostasis bows out of cystic fibrosis drugmaking through Yumanity merger

·

·

Proteostasis bows out of cystic fibrosis drugmaking through Yumanity merger

Yumanity Therapeutics plans to come to the Nasdaq stock exchange through a reverse merger with Proteostasis Therapeutics, a 15-year-old biotech that has been developing drugs for cystic fibrosis. The deal announced Monday would have Proteostasis …
See Original Article

Boeing May Be Quietly Rebranding the 737 MAX

Aircraft orders have been few and far between for Boeing (NYSE:BA) this year. And as of the end of July, the 737 MAX family — which accounts for the vast majority of Boeing’s backlog but has been grounded for 17 months following two fatal crashes — had not …
See Original Article

Texas development heavyweight Gerald Hines dies at 95

Gerald D. Hines photographed with Houston’s Pennzoil Place. Hines founded his eponymous Houston-based real estate company in 1957. He died peacefully in his home on Sunday, August 23 at age 95. Annie Leibovitz | Photo courtesy of Hines.
See Original Article

Moderna, EU conclude advanced talks to supply COVID-19 vaccine candidate

(Reuters) – Moderna Inc (MRNA.O) said on Monday it has concluded advanced talks with the European Union to supply 80 million doses of its COVID-19 vaccine candidate, which is currently in late-stage testing. The potential agreement provides for an option …
See Original Article

Seven-Day Virus Disinfectant Is Cleared for American Air Jets

The Trump administration on Monday gave American Airlines Group Inc. emergency approval to deploy a new weapon against Covid-19: a surface coating that kills coronaviruses for as many as seven days. Environmental Protection Agency Administrator …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.